111 related articles for article (PubMed ID: 11137388)
21. Behavioral changes induced by the thyrotropin-releasing hormone analogue, RGH 2202.
Drago F; Grassi M; Valerio C; Coppi G; Lauria N; Nicotra GC; Raffaele R
Peptides; 1991; 12(6):1309-13. PubMed ID: 1815218
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial superoxide production in kainate-induced hippocampal damage.
Liang LP; Ho YS; Patel M
Neuroscience; 2000; 101(3):563-70. PubMed ID: 11113305
[TBL] [Abstract][Full Text] [Related]
23. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models.
Kelly JA; Boyle NT; Cole N; Slator GR; Colivicchi MA; Stefanini C; Gobbo OL; Scalabrino GA; Ryan SM; Elamin M; Walsh C; Vajda A; Goggin MM; Campbell M; Mash DC; O'Mara SM; Brayden DJ; Callanan JJ; Tipton KF; Della Corte L; Hunter J; O'Boyle KM; Williams CH; Hardiman O
Neuropharmacology; 2015 Feb; 89():193-203. PubMed ID: 25281210
[TBL] [Abstract][Full Text] [Related]
24. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate.
Jourquin J; Tremblay E; Décanis N; Charton G; Hanessian S; Chollet AM; Le Diguardher T; Khrestchatisky M; Rivera S
Eur J Neurosci; 2003 Sep; 18(6):1507-17. PubMed ID: 14511330
[TBL] [Abstract][Full Text] [Related]
25. Nicotine protects against the dexamethasone potentiation of kainic acid-induced neurotoxicity in cultured hippocampal neurons.
Semba J; Miyoshi R; Kito S
Brain Res; 1996 Oct; 735(2):335-8. PubMed ID: 8911675
[TBL] [Abstract][Full Text] [Related]
26. Changes in brain thyrotropin-releasing hormone (TRH) of El mice.
Yamashita K; Nakashima M; Kajita S; Hiramatsu M; Ogawa N; Mori A; Sato M
Jpn J Psychiatry Neurol; 1987 Sep; 41(3):383-5. PubMed ID: 2834594
[TBL] [Abstract][Full Text] [Related]
27. Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro.
Rozovsky I; Morgan TE; Willoughby DA; Dugichi-Djordjevich MM; Pasinetti GM; Johnson SA; Finch CE
Neuroscience; 1994 Oct; 62(3):741-58. PubMed ID: 7870303
[TBL] [Abstract][Full Text] [Related]
28. Influence of TRH and TRH analogues RGH-2202 and DN-1417 on cultured ventral spinal cord neurons.
Askanas V; Engel WK; Eagleson K; Micaglio G
Ann N Y Acad Sci; 1989; 553():325-36. PubMed ID: 2497677
[No Abstract] [Full Text] [Related]
29. Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield.
Magloczky Z; Freund TF
Neuroscience; 1993 Sep; 56(2):317-35. PubMed ID: 8247263
[TBL] [Abstract][Full Text] [Related]
30. Kainate excitotoxicity is mediated by AMPA- but not kainate-preferring receptors in embryonic rat hippocampal cultures.
Ohno K; Okada M; Tsutsumi R; Kohara A; Yamaguchi T
Neurochem Int; 1997 Nov; 31(5):715-22. PubMed ID: 9364457
[TBL] [Abstract][Full Text] [Related]
31. Increase in hippocampal cell death after treatment with kainate in zinc deficiency.
Takeda A; Tamano H; Nagayoshi A; Yamada K; Oku N
Neurochem Int; 2005 Dec; 47(8):539-44. PubMed ID: 16169125
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of lactate dehydrogenase A in a chronic model of temporal lobe epilepsy.
Sada N; Suto S; Suzuki M; Usui S; Inoue T
Epilepsia; 2020 May; 61(5):e37-e42. PubMed ID: 32202309
[TBL] [Abstract][Full Text] [Related]
33. 3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility.
Abad S; Junyent F; Auladell C; Pubill D; Pallàs M; Camarasa J; Escubedo E; Camins A
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():231-42. PubMed ID: 24977329
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.
Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W
Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113
[TBL] [Abstract][Full Text] [Related]
35. Systemic administration of kainic acid induces selective time dependent decrease in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in adult rat hippocampal formation.
Kar S; Seto D; Doré S; Chabot JG; Quirion R
Neuroscience; 1997 Oct; 80(4):1041-55. PubMed ID: 9284059
[TBL] [Abstract][Full Text] [Related]
36. Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats.
Shih YH; Chein YC; Wang JY; Fu YS
Neurosci Lett; 2004 May; 362(2):136-40. PubMed ID: 15193771
[TBL] [Abstract][Full Text] [Related]
37. Excitatory amino acid analogues: neurotoxicity and seizures.
Zaczek R; Coyle JT
Neuropharmacology; 1982 Jan; 21(1):15-26. PubMed ID: 7063105
[TBL] [Abstract][Full Text] [Related]
38. Neuropharmacological profile of L-pGlu-(1-benzyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog: effects on seizure models, sodium current, cerebral blood flow and behavioral parameters.
Rajput SK; Singh JN; Ingole S; Jain G; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
Epilepsy Res; 2009 Dec; 87(2-3):223-33. PubMed ID: 19833480
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of the lysosomal protease cathepsin S in hippocampal microglia following kainate-induced seizures.
Akahoshi N; Murashima YL; Himi T; Ishizaki Y; Ishii I
Neurosci Lett; 2007 Dec; 429(2-3):136-41. PubMed ID: 17997037
[TBL] [Abstract][Full Text] [Related]
40. Ability of GDNF to diminish free radical production leads to protection against kainate-induced excitotoxicity in hippocampus.
Cheng H; Fu YS; Guo JW
Hippocampus; 2004; 14(1):77-86. PubMed ID: 15058485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
